Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2206-2213
Published online before print July 26, 2007, doi: 10.1161/ATVBAHA.107.141846
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/10/2206    most recent
ATVBAHA.107.141846v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krebs, P.
Right arrow Articles by Ludewig, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krebs, P.
Right arrow Articles by Ludewig, B.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2206.)
© 2007 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Chronic Immune Reactivity Against Persisting Microbial Antigen in the Vasculature Exacerbates Atherosclerotic Lesion Formation

Philippe Krebs; Elke Scandella; Beatrice Bolinger; Daniel Engeler; Simone Miller; Burkhard Ludewig

From the Research Department, Kantonal Hospital St Gallen, St Gallen, Switzerland.

Correspondence to Burkhard Ludewig, Research Department, Kantonsspital St Gallen, Rorschacherstrasse 95, CH-9007 St Gallen, Switzerland. E-mail burkhard.ludewig{at}kssg.ch

Objective— The purpose of this study was to examine the relative contribution of different immunopathological mechanisms during murine cytomegalovirus (MCMV)-mediated acceleration of atheroma formation in apolipoprotein E–deficient (apoE–/–) mice.

Methods and Results— To distinguish between the effects of systemic activation and cognate immune reactivity against a pathogen-derived persisting antigen in the vasculature, we used hypercholesterolemic transgenic mice constitutively expressing the β-galactosidase (β-gal) transgene in the cardiovascular system (apoE–/–xSM-LacZ). After infection with β-gal–recombinant MCMV-LacZ, apoE–/–, and apoE–/–xSM-LacZ mice mounted comparable cellular immune responses against the virus. β-gal–specific CD8+ T cells expanded rapidly and remained detectable for at least 100 days in both mouse strains. However, compared with apoE–/– mice, apoE–/–xSM-LacZ mice developed drastically accelerated atherosclerosis. Moreover, atherosclerotic lesions in MCMV-LacZ–infected apoE–/–xSM-LacZ but not apoE–/– mice were associated with pronounced inflammatory infiltrates.

Conclusions— Taken together, our data indicate that chronic immune reactivity against pathogen-derived antigens persisting in the vasculature significantly exacerbates atherogenesis.

This study demonstrates that T cell responses directed against persisting microbial antigen within the vasculature favor the development of an inflammatory environment that is important for the acceleration of atherosclerotic lesion development.


Key Words: cytomegalovirus • atherosclerosis • inflammation • immunopathology • coronary heart disease